Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1

Details for Australian Patent Application No. 2006304434 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Balkovec, James M.; Kevin, Nancy J.; Waddell, Sherman T.; Gu, Xin

Agent Spruson & Ferguson

Pub. Number AU-B-2006304434

PCT Pub. Number WO2007/047625

Priority 60/728,723 20.10.05 US

Filing date 16 October 2006

Wipo publication date 26 April 2007

Acceptance publication date 5 April 2012

International Classifications

C07D 413/08 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

Event Publications

10 April 2008 PCT application entered the National Phase

  PCT publication WO2007/047625 Priority application(s): WO2007/047625

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

5 April 2012 Application Accepted

  Published as AU-B-2006304434

2 August 2012 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006304449-Idler assembly, and method for retrofitting an existing idler assembly

2006304421-Powered wheelchair having side access battery compartment